Dan Hall of Extend Biosciences attends the annual radiation research society meeting

The 64th annual RRS meeting was held in Chicago in conjunction with the Conference on Radiation Health.

Visit conference website ->

Founder Laura Hales attends the 4th Cancer Cachexia Conference

Philadelphia was host to the 4th Cancer Cachexia Conference, which was sponsored by Pfizer, NCI, Indiana University and Ohio State University.

Visit conference website ->

Extend Biosciences receives an SBIR supplemental award

The company received an Administrative Supplement award from NCI to further the development of the long-acting ghrelin asset for the treatment of cancer cachexia.

The US Patent and Trademark office awards Extend Biosciences with a mark for D-VITylation

Extend Biosciences’ trademark registration has been issued for the name of their platform technology, D-VITylation.

Founder Laura Hales attends BIO2018

The largest international convention in the biotech/pharma sector was held in Boston this year, and marked their 25th anniversary by setting a Guinness Book of World Record for the largest business partnering event.

Founder Laura Hales attends PODD

The 7th annual Partnership Opportunities in Drug Delivery conference, held in Boston, featured a keynote by Dr. Jeffrey Kart of Harvard Medical School and Brigham and Women’s Hospital.

Visit conference website ->

Founder Laura Hales speaks on a panel about Extend Biosciences’ non-dilutive funding path

Laura Hales was one of three panelists at an event sponsored by ENET titled “SBIR grants and non-dilutive funding to bootstrap your startup company”.

See event details here ->

Extend Biosciences is awarded a Phase II SBIR grant from NIDDK

Extend Biosciences’ long-acting PTH molecule will advance through IND-enabling studies with a Phase II grant from NIDDK.

NIDDK awards Extend Biosciences with a Phase I grant

Extend Biosciences was awarded a Phase I SBIR grant to advance their long-acting insulin molecule for the treatment of diabetes.

Founder Laura Hales speaks on a panel sponsored by The Capital Network

At an event titled “SBIR – America’s Largest Seed Fund”, Extend Biosciences founder Laura Hales spoke about her experience winning SBIR grants.

See event details here ->